Bubnovskaya Larissa N*
Department of Metastatic Problems of Tumor Microenvironment, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Science of Ukraine, Ukraine
*Corresponding Author: Bubnovskaya Larissa N, Department of Metastatic Problems of Tumor Microenvironment, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Science of Ukraine, Ukraine
Received: May 28, 2020; Published: July 01, 2020
In December 2019, the novel coronavirus (CoV), SARS-CoV-2, has emerged in China. The disease caused by SARS-CoV-2 was named as COVID-19 by the World Health Organization (WHO). The emergence of SARS-CoV-2 and its rapid spread across the world has triggered a global health emergency. Nevertheless, so far there exist no specific antiviral drugs for treatment of the disease, which poses great challenge to control and contain the virus The pathological features of patients with COVID-19 are very similar to those of patients with SARS and MERS (Middle East Respiratory Syndrome) infection. However, COVID-19 is more contagious than SARS and MERS. .
Citation: Bubnovskaya Larissa N. “Some Remarks about CD147”.Acta Scientific Cancer Biology 4.8 (2020): 01-02.
Copyright: © 2020 Bubnovskaya Larissa N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
